Renaissance Technologies’s Pyxis Oncology PYXS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Sell |
417,822
-164,314
| -28% | -$181K | ﹤0.01% | 2876 |
|
|
2025
Q1 | $570K | Buy |
582,136
+288,782
| +98% | +$283K | ﹤0.01% | 2689 |
|
|
2024
Q4 | $458K | Buy |
293,354
+133,018
| +83% | +$208K | ﹤0.01% | 2883 |
|
|
2024
Q3 | $588K | Buy |
160,336
+63,400
| +65% | +$233K | ﹤0.01% | 2710 |
|
|
2024
Q2 | $321K | Sell |
96,936
-51,064
| -35% | -$169K | ﹤0.01% | 2884 |
|
|
2024
Q1 | $630K | Sell |
148,000
-216,150
| -59% | -$920K | ﹤0.01% | 2770 |
|
|
2023
Q4 | $655K | Buy |
364,150
+147,899
| +68% | +$266K | ﹤0.01% | 2650 |
|
|
2023
Q3 | $430K | Sell |
216,251
-36,978
| -15% | -$73.5K | ﹤0.01% | 2780 |
|
|
2023
Q2 | $648K | Buy |
253,229
+159,029
| +169% | +$407K | ﹤0.01% | 2735 |
|
|
2023
Q1 | $378K | Buy |
94,200
+10,600
| +13% | +$42.5K | ﹤0.01% | 3011 |
|
|
2022
Q4 | $112K | Sell |
83,600
-45,202
| -35% | -$60.6K | ﹤0.01% | 3579 |
|
|
2022
Q3 | $254K | Buy |
128,802
+53,431
| +71% | +$105K | ﹤0.01% | 3276 |
|
|
2022
Q2 | $179K | Buy |
+75,371
| New | +$179K | ﹤0.01% | 3690 |
|